Congenital virilizing adrenal hyperplasia miiay present a varied clinical picture. Patients have been described who have only excessive virilization (1); others have an associated Addison-like electrolyte disturbance (2, 3), with hypoglycemia (4), or with hypertension (5-9). Recent studies (10) (11) (12) indicate that the manifestation of virilism may result from defects in the biosynthesis of cortisol.' The first suggestion regarding the nature of the error was made by Lewis and Wilkins (12), and * This study was supported by a grant (C-1003) from the National Cancer Institute, Bethesda, Md. 
The following trivial names are used in the text: Hydrocortisone (Compound F) is 1l11, 17a, 21-trihydroxy-4-pregnene-3,20-dione. Tetrahydrocortisol (tetrahydro F) is 3a, llp, 17a, 21-tetrahydroxy-pregnane-20-one. Cortisone (Compound E) is 17a, 21-dihydroxy-4-pregnene-3,11,-20-trione. Tetrahydrocortisone (tetrahydro E) is 3a, 17a, 21-trihydroxy-pregnane-11,20-dione. 11-Desoxyhydrocortisone (Compound S) is 17a, 21-dihydroxy-4-pregnene-3,-20-dione. Tetrahydro S is 3a, 17a, 21-trihydroxy-pregnane-20-one. Dihydro S is 17a, 21-dihydroxy-pregnane-3,20-dione. Corticosterone (Compound B) is 11,, 21-dihydroxy-4-pregnene-3,20-dione. Tetrahydrocorticosterone (tetrahydro B) is 3a, lip, 21-trihydroxy-pregnane-20-one. Desoxycorticosterone (DOC) is 21-hydroxy-4-pregnene-3,20-dione. Tetrahydrodesoxycorticosterone is 3a, 21-dihydroxy-pregnane-20-one. Dihydrodesoxycorticosterone is 21-hydroxy-pregnane-3,20-dione. Allo-dihydrodesoxycorticosterone acetate is 21 acetoxy-allo-pregnane-3,20-dione. Twenty-one desoxycortisone is 17a-hydroxy-4-pregnene-3,-11,20-trione. Pregnanetriol is pregnane-3a, 17a, 20a-triol. Pregnanediol is pregnane-3a, 20a-diol. Androsterone is 3a-hydroxyandrostane-17-one. Etiocholanolone is 3a-hydroxy-etiocholane-17-one. 11 -Keto androsterone is 3a-hydroxy-androstane-11,17-dione. 11 Ketoetiocholanolone is 3a-hydroxy-etiocholane-11,17-dione. 11 Hydroxyandrosterone is 3a, 11-dihydroxy-androstane-17-one. 11 Hydroxyetiocholanolone is 3a. 1 lp-dihydroxy-etiocholane-17-one.
corroborated by Bartter and associates (13) . Dorfman (14) postulated that there is a deficiency in the C-21 hydroxylation mechanism. Eberlein and Bongiovanni (15) then found that some patients with congenital virilizing adrenal hyperplasia excreted C-21 hydroxylated compounds in approximately the same quantities as did normal individuals. Tetrahydrocortisone in small amounts was found. The present authors (16) have studied six patients with virilizing adrenal hyperplasia in addition to the one reported here. Each of these was found to be excreting C-21 hydroxylated compounds in amounts equal to those found in normals of com)parable age. Tetrahydrocortisol was one of the a-ketols present. More recently, both tetrahydrocortisone and tetrahydrocortisol have been found in the urine of patients with this disorder (17) (18) (19) (20) .
Abnormally high excretion of precursors of cortisol, metabolites of precursors, and androgens are well recognized consequences of the derangement in the pathway for synthesis of normial corti- costeroids. Further augmentation of the amounts of such products is to be expected fromii the overstimulation by excess corticotropin. The identification of some of the abnormal metabolites has led to the clarification of the probable location of the errors in the synthetic process (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . Laboratory and clinical data reported by many workers favor the concept that the defect in some cases may be at two or more steps of the steroid svnthesis.
Eberlein and Bongiovanni (7) (8) (9) studied an untreated patient who had congenital adrenal hyperplasia associated with hypertension. The plasma and urinary 17-hydroxycorticosteroids were imiarkedly elevated. The plasma contained Comlpound S and tetrahydro S. The predomiiinant compound in 364 Downloaded from http://www.jci.org on October 20, 2017 . https://doi.org/10.1172/JCI104047 the urine was tetrahydro S. Tetrahydrodesoxycorticosterone was also identified.
Three nonketonic C,1 steroids and two C19-17-ketosteroids were isolated and identified by infrared spectroscopy. None of the compounds isolated had oxygen functions at the 11-carbon. The authors proposed that these findings were evidence for deficiencv in C-11 hydroxylation. They also suggested that the hypertension may be attributed to accumulation of desoxycorticosterone, and this type of defect has been considered characteristic of congenital adrenal hyperplasia when hypertension is a complication (21 The blood pressure was recorded by 3 different examiners to be 100/65, 105/70 and 120/80, respectively. Numerous other observers always found it to be within these limits. After 3 years' treatment with cortisone, the drug was discontinued for 2 weeks. At the end of this time the blood pressure was again found to be normal. The other remarkable features of the physical examination were limited to a penis measuring 9 cm in length and small testes and prostate. The bone age, according to Todd's "Atlas of Skeletal Maturation," corresponded to that of 11 years and 9 months. The neutral 17-ketosteroids ranged from 15.7 to 21.7 mg per day for 4 successive days before this investigation began. Urinary a-ketol excretion, measured as blue tetrazolium reducing substances (23) , ranged from 18.6 to 27.7 mg per 24 hours. The normal range for children 5 to 7 years of age was found to be 2.5 to 3.5 mg per 24 hours in our laboratory. Excretion of pregnanetriol and pregnanediol, determined according to the method of Bongiovanni (24) was 4.5 and 1.5 mg per day, respectively. Serum electrolytes, hemogram, blood sugar anid urinalysis were normal.
One week after the administration of 25 mg of cortisone acetate orally every 12 hours, the urinary neutral 17-ketosteroid excretion and total corticoid excretion had decreased to 2.5 and 12.4 mg per 24 hours, respectively. The excretion of both types of steroids rose to pretreatment levels 48 hours after the cortisone was discontinued. The patient was then placed on 37.5 mg of cortisone orally per day in divided doses for the next 9 months. During that time the 17-ketosteroid excretion ranged between 1.2 and 2.5 mg per 24 hours. Urinary pregnanetriol and pregnanediol were found to be 1.7 and 0.8 mg, respectively, per day. No change in the range of systolic or diastolic blood pressure was noted during the trial of cortisone, when the drug was stopped, or during maintenance therapy.
METHODS
Corticosteroids. A 3 day pool of urine was collected before treatment and again a week after cortisone therapy had been started. Twenty-four hour aliquots from each pool were buffered at pH 4.8, hydrolyzed for 48 hours at 470 C with p-glucuronidase (250 units per ml of urine), and then continuously extracted xith ether for 48 hours after the pH had been readjusted to 6.8. The extracted urine was put aside and the ether extracts were dried and washed in chloroform by the procedure described by Burton, Zaffaroni and Keutmann (25) . The number of washings was reduced to 3 alkali, 1 acid, and 1 water wash, together with their appropriate back washings. Preliminary fractionation and identification were done on one of the 24 hour aliquots, the other two were used for more definite and confirmatory information both as to identity and quantitation.
The total a-ketol content of the neutral extracts was measured with blue tetrazolium according to the method described by Izzo, Keutmann and Burton (23) prior to and after chromatographic fractionation on paper. The total C-21, 17-hydroxyglycol content was determined by the method of Wilson and Fairbanks (26) , and total 17-ketosteroid content by the method of Talbot, Berman and MacLachlan (27) , using alcoholic KOH prepared according to Wilson and Carter (28) . The amounts of the individual fractions or compounds were determined on known aliquots of eluates from the paper after the compound had been located with the appropriate spotting reagent. Quantities of individual compounds other than the above types were quantitated by methods which will be indicated in each instance. In order to insure against loss of a-ketols, no preliminary separation into various types of the steroids in this extract was attempted. Dur Fractionation of each urine extract by paper chromatography was similar to that described by Burton (37, 38) ; and treatment with trichloracetic acid (39) .
The reference strips treated with blue tetrazolium indicated that the a-ketols were grouped in 3 zones at this time as illustrated in Figure 1 . These were eluted separately and designated as subfractions C-1, C-2 and C-3 ( Figure 1 and Table I ). Fractions A and B were rechromatographed in the cyclohexane/formamide and the benzene/formamide systems, respectively, as indicated in Figure 1 . Steroids were located on reference strips from each of these chromatograms with the group-specific spotting reagents enumerated above. Just as had been done with Fraction C, these chromatograms were divided into subfractions corresponding to blue tetrazolium reactive zones.
The eluates of each of these were rechromatographed in the appropriate systems ( Figure 1 ). In many instances it was necessary to rechromatograph a subfraction or an isolated steroid several times in order to achieve separation of two different group-specific reacting areas or to eliminate urinary pigments. Complete separation was at times not achieved until acetates were made and chromatographed (35) . This was especially true for mixtures of a-ketols and other C-21 compounds which had the same mobility. These mixtures were separated most efficiently when undiluted formamide was used as the stationary phase.
Characterization was attempted in the case of each isolated steroid. The criteria for identification were: a) the chromatographic mobility in the free state and as acetates compared with authentic compounds and their acetates; b) reactions of the unknown compounds on paper with the aforementioned group-specific reagents; c) the absorption spectra in methanol and sulfuric acid, respectively (40) ; and in most instances, d) infrared absorption spectra. Well defined spectra were obtained when the acetates either were partitioned between purified ethyl ether and ice water, or were passed through a micro-column of silica gel, or both.
Non-a-ketolic C-21 steroids. These steroids were located on the toluene/propylene glycol chromatograms by means of those spot tests, enumerated earlier, which did not test for a-ketols but have been found to react with groupings on the molecule which apply specifically here (32) (33) (34) (35) (36) (37) (38) (39) . In some instances there was overlapping on the chromatograms with a-ketols of similar polarity, and complete separation, sufficiently satisfactory for complete identification, was not accomplished until after acetylation.
Seventeen-ketosteroids. The urines which had been extracted at pH 6.8 after enzyme hydrolysis were next adjusted to pH 1 with 50 per cent sulfuric acid and again continuously extracted with ether for 48 hours. These extracts were dried and washed in the same manner as those containing largely the a-ketolic steroids. The total amounts of Zimmermann-reacting substances were then measured. Separation of the individual 17-ketosteroids was accomplished by paper chromatography utilizing the benzene/formamide, cyclohexane/formamide, and cyclohexane: hexane/formamide systems (25) . The Zimmermann reaction, when used to spot the compounds on the paper, was performed with aqueous KOH. For quantitation, alcoholic KOH (28) was used. The overflow from Fraction A of the a-ketol procedure was chromatographed with cyclohexane: hexane/formamide, the spots located, identified and quantitated, and the results pooled with those of the pH 1.0 extract (Table II) . Six compounds were present in sufficient quantity for ready separation, quantitation, and identification by comparing their mobilities and infrared absorption spectra with authentic compounds. In addition there were 5 compounds which were present in insufficient quantity to identify definitely.
RESULTS
Corticosteroids. The steroids isolated and identified prior to any treatment of the patient and during cortisone therapy are listed in Table I Figure   1 , accounted for 68 per cent of the total a-ketolic steroids excreted per 24 hours. The free compound as well as its acetate had the same chromatographic mobilities as had authentic tetrahydro S and its acetate. The free compound and its acetate reacted with blue tetrazolium to give an intense blue color. When the compound was dissolved in methanol, no peak was found in the ultraviolet absorption spectrum. The sulfuric acid chromogen of both the free compound and its acetate gave an absorption peak at 314 mu and a plateau extending from 400 to 420 m,u. This pattern was identical to what we observed with known tetrahydro S (T.H.S.). An infrared absorption spectrum of the acetylated compound in carbon di- Table   I were spotted in this extract. Tetrahydrocortisol. Compounds 1 and 2 were not separated in the free state with the toluene/ prol)ylene glycol and chloroform/formamide sys-tems. As acetates they were separated from one another when chromatographed in the benzene: cyclohexane/formamide system. The chromatographic mobility of the acetate of Compound 2 was identical to that of authentic tetrahydrocortisol diacetate in a mixed chromatogram. An absorption spectrum given by the sulfuric acid chromogen and the infrared absorption spectrum of the acetylated compound in a potassium bromide disc was identical with that of authentic tetrahydrocortisol.
Tetrahydrocortisone. Compound 4 exhibited chromatographic mobility identical to that of authentic tetrahydrocortisone in the free state and as acetate. Its reaction with blue tetrazolium, its nonreactivity with the other spotting reagents, and its failure to absorb ultraviolet light characterized it as a saturated a-ketol. The sulfuric acid chromogen and the infrared absorption spectra were identical to those of known tetrahydrocortisone diacetate.
Dihydro S. Compound 8 behaved like dihydro S. In the free form and as acetate it exhibited polarity similar to Compound E and its acetate. However, it gave a color, when treated on paper with 2,4 dinitrophenylhydrazine, which suggested the presence of a nonconjugated ketone group in Ring A. The sulfuric acid chromogen pattern was identical to that of authentic dihydro S.
Dihydrodesoxycorticosterone and tetrakydrodesoxycorticosterone. The two a-ketols found in Fraction A (Compounds 16 and 17) were of more than ordinary interest. Alpha-ketols have not been found in the urine of normal persons in this fraction (25, 41 hexane: benzene/formamide systems. The sulfuric acid chromogen and the infrared absorption spectra were identical to those given by authentic tetrahydrodesoxycorticosterone. Alpha-ketols not completely characterized. Five additional a-ketolic compounds were separated in varying amounts (Compounds 1, 3, 9, 13, 15). All seemed to be saturated in Ring A. Many of the characteristics of Compounds 1 and 3 suggested that they were probably "allo" isomers of tetrahydro F and tetrahydro E, respectively (43, 44) . The polarity of the others ranged from slightly less than that of cortisone to slightly less than that of 11-dehydrocorticosterone. Neither their chromatographic behavior as free steroids, or as acetates, their sulfuric acid chromogen spectra, nor the various spot tests or derivatives aided in their identification. Compound 9 may possibly have been tetrahydro A contaminated with another steroid. The sulfuric acid chromogen curve did not resemble the two identified steroids found next to it.
Non-a-ketolic C-21 steroids. Two glycols were found in Fraction C-2 of the toluene/propylene glycol chromatogram. The total amount per 24 hours was 1.6 mg.
Pregnane-3a, 17a, 20$, 21-tetrol. This compound (no. 5 in Figure 1 and Table I It did not become fluorescent when treated with sodium hydroxide and no color was produced with dinitrophenylhydrazine. Its sulfuric acid chromogen had a peak at 314. An infrared absorption spectrum had peaks which were identical to those described by Eberlein and Bongiovanni (9) for this compound.
When the compound was oxidized a 17-ketosteroid was produced which, when chromatographed in the cyclohexane/formamide system, had mobility identical to etiocholanolone.
Three a, 17a, 20a-trihydroxy-pregnane-11-one.
This compound (no. 7 in Figure 1 and Table I Figure 1 . It was less polar than tetrahydro B and tetrahydro A, both in the free form and as acetates. The acetate was also less polar than desoxycorticosterone acetate. The free compound, when located on the paper chromatograms with phosphoric acid, gave a violet color and pink fluorescence (37, 38) . When treated with trichloracetic acid (39) it gave a blue color in daylight and blue fluorescence. It did not react with blue tertazolium and all reactions for 4, 3-keto groups were negative. After periodate oxidation, according to the method of Romanoff and Hunt (34), it gave a weak Zimmermann reaction. With phosphomolybdic acid it gave a blue color (36) . In sulfuric acid it formed a pale orange color (9) and its sulfuric acid chromogen absorption spectrum had a major peak at 440, a minor peak at 310 and a shoulder at 510.
The amount, in addition to having been done on an aliquot of urine as mentioned in the case report, was again quantitated by eluting the compound off the paper and applying the formula of Allen to the absorption spectrum obtained with a sulfuric acid chromogen. In this manner 4.8 mg per 24 hours was calculated to be present.
Three a, 17a-dihydroxy-pregnane-20-one. This compound (no. 11 in Table I ) was detected on the paper by its reaction with 2,4-dinitrophenylhydrazine, thus characterizing a ketone group in the molecule. Its polarity was somewhat less than dihydro S and pregnanetriol. It did not reduce blue tetrazolium and did not have an ultraviolet light absorption peak when dissolved in methanol. After chromatography of the acetate its sulfuric acid chromogen absorption spectrum consisted of a peak at 320 m,u. This was identical to the spectrum yielded by authentic 3a, 17a-dihydroxy-pregnane-20-one (42) . An infrared absorption spectrum also coincided with that given by this compound. While most of the compound was sharply localized in this region of the chromatogram, traces were also distributed to some extent throughout Fractions B and A in the preliminary fractionation and necessitated rechromatography of certain of the other steroids in order to clean them up satisfactorily for identification. Similar difficulties were encountered by Fukushima and Gallagher (17) when a urine extract contained large amounts of pregnane-3ca, 17a, 20a-triol. From the aliquot used 8.4 mg of the compound in crystalline form was isolated, and this accounted for an excretion of slightly more than 25 mg daily.
Pregnane-3a, 20a-diol was found in Fraction A by spotting with phosphomolybdic and silicotungstic acids. It was cleaned up by chromatography using a toluene: methyl cyclohexane/propylene glycol system and identified by its sulfuric acid and infrared absorption spectra.
Two other nonketolic substances were isolated from Fraction B (Compounds 11 and 13 ). These substances, like Compound 9, reacted with 2,4-dinitrophenylhydrazine. From the chromatographic mobility of Compound 13 before and after acetylation we inferred formation of a diacetate. Further identification was not possible. A number of lesser spots were found during treatment with phosphoric acid and phosphomolybdic acid, but their nature was not determined.
Seventeen-ketosteroids. The three 24 hour urine specimens contained an average of 17 mg of 17-ketosteroid after hydrolysis with hot hydrochloric acid. In order to avoid the confusion caused by artifacts produced by the hot acid (45) the chromatography and identification were performed on extracts prepared as described in "Methods." This, we believe, assured us that the identified metabolites were excreted as such by the patient.
In Table II are recorded the six C19 compounds which were isolated, quantitated and identified by their infrared absorption spectra. Five additional compounds were found in minute amounts, too small to identify. These are all included in the table under "unidentified." The sum of the 17-ketosteroids thus found was 12.2 mg. According to the work of Brooks (29) this is a reasonable amount when compared with the quantity found after hot acid hydrolysis.
Cortisone treatment period. The excretion of 17-ketosteroids reverted to normal levels while the patient was receiving cortisone. There was also a decrease in the daily excretion of a-ketols and there was a marked change in their pattern. The predominant a-ketols were tetrahydrocortisol and tetrahydrocortisone which accounted for approximately 57 per cent of the total a-ketols excreted. A small amount of tetrahydro B was also found. It is possible that its presence in small amounts during the pretreatment period was missed because of the large quantities of abnormal steroids located in the same regions of the chromatogram (Fraction B-1) . It could also have been due to contamination of the administered cortisone by Compounds A or B. The metabolites of Compound S and desoxycorticosterone noted prior to cortisone therapy were not found. Some of the unidentified compounds exhibited properties identical to some of the unidentified compounds found during the pretreatment period. This phenomenon may have been due to the cortisone dosage being insufficient to suppress completely ACTH production.
DISCUSSION
Adrenal gland perfusions and adrenal vein blood analyses indicate that cortisol and cortisone are the major products of adrenocortical secretion in man. The synthesis of Compound F via pregnenolone (46) is dependent upon hydroxylating enzymes which introduce oxygen function at C-17, C-21 and C-11 positions, usually in sequential fashion in the order named, according to Hechter and Pincus (47) .
Patients exhibiting congenital adrenal hyperplasia with virilization are considered to have a metabolic defect which does not allow synthesis of cortisol at a normal rate. All of the clinical and laboratory findings which have been reported are in keeping with this hypothesis. In the plasma, low levels of 17-hydroxycorticoids and high levels of ACTH have been reported (11) . Administration of adrenocorticotropin usually has not augmented appreciably the levels of corticoids in the serum or urine (10-13, 48, 49) . Exceptions to this have been reported (16, 50) . These variations of response from case to case probably depend upon whether or not the adrenals are responding maximally to intrinsic ACTH before administration of the extrinsic material. This in turn may depend upon differences in the quantitative extent of the defect. In the cases described prior to 1955 the known metabolites of cortisol were not found (7, 8, 11) . Since then, however, both tetrahydrocortisone and tetrahydrocortisol have been isolated from the urines of untreated patients with adrenogenital syndrome (15) (16) (17) (18) . The explanation proposed by Bongiovanni and Eberlein, and which has been supported by others (18) , namely, that the fault is relative and not absolute, explains these findings in a highly satisfactory manner. Indeed, the ability to synthesize, with sufficient stimulation by ACTH, adequate amounts of cortisol probably explains why most of these patients remain in good general health. The urinary steroid pattern in the case described here had certain similarities to that found in the case with hypertension reported by Eberlein and Bongiovanni (9); however, there were marked differences in both kind and amount of metabolites isolated. In Figure 2 we have indicated the most probable precursors of the various C21 metabolites found in the urine of our patient. Implications as to the abnormalities in synthesis are derived from the amounts and types of these metabolites. At the same time the presence of the 17-ketosteroids listed in Table II should be taken into consideration.
The levels of excretion of metabolites of Compound S and of desoxycorticosterone in the two patients were of roughly the same order. In ours we found slightly more tetrahydro S but in the case of Eberlein and Bongiovanni (9) (54) . In some patients wN-ith adrenal cortical tumlors considerable quantities of tetrahydro S have been found in the urine (54) (55) (56) , probably because the production of Compound S was so great that the capacity of the 11-hydroxylating mechanism was exceeded, or the subjects hadl defects in the 11-hvdroxylating mechanism.
The most striking (lifference between the case reported here an(l that of Eberlein and Bongiovanni (9) Figure 2 . The amiiounts were verified by repeated analyses on several aliquots of the three 24 hour specimens. Three a, 1 7a, 20-trihydroxypregnane-11-one, a metabolite of 21-desoxycortisone, was almost certainly also found. All these metabolites have been found in cases of adrenogenital syndrome with deficiency of C-21-hydroxylation (16 In almost all studies involving the administration of desoxycorticosterone to animals or man there have been wide variations in the degree of response by individuals or groups of individuals. This was noted in the earliest reports concerning the use of this hormone in the treatment of Addison's disease (62) (63) (64) . The patients varied greatly in the amount of hormone esters required to alleviate the manifestation of adrenal insufficiency. With the same doses wide variations were noted in sodium chloride and water retention, in body weight changes, edema formation, and effects on blood pressure.
When desoxycorticosterone was given to normotensive, spontaneously hypertensive, and Goldblatt-hypertensive dogs, 9 out of 12 dogs developed hypertension; 3 did not (65) . Perera and Blood (66) administered desoxycorticosterone to 10 normotensive and 15 hypertensive individuals while they were under strict metabolic control. The normotensive individuals developed no change of basal blood pressure, while in the hypertensives both systolic and diastolic pressures increased. The authors were of the opinion that changes in body weight and salt balance were the same in both groups; therefore, they did not accept electrolyte retention as being the crucial factor responsible for the increase in blood pressure.
Some of the work by Davies and Clark (67) suggests that increase of blood pressure after administration of desoxycorticosterone may not result from a direct effect of the steroid on blood vessels, but the hormone may condition them for an increased response to pressor substances. They administered 5 mg of desoxycorticosterone acetate twice daily to 15 individuals for 15 days. The response to injection of epinephrine and norepinephrine was measured repeatedly before and after treatment with desoxycorticosterone acetate. While the resting pressures were not significantly altered, there was invariably an increase of pressor response after pretreatment with desoxycorticosterone acetate.
Recently Liddle and associates (68) and Jenkins and associates (69) gave an 11,8-hydroxylase inhibitor (2-methyl-1,2-bis [3-pyridyl] -1-propanone) to normal nonstressed persons. Compound S and other 11-desoxycorticosteroids were isolated from the serum and large quantities of their metabolites were isolated from the urine of these subjects. The blood pressure was not affected; it is entirely possible that it would have been with longer administration or larger doses. Experience with administration of desoxycorticosterone to patients with Addison's disease certainly showed that, when larger doses of this drug were given, it took several months in some patients for the blood pressure to reach hypertensive levels.
SUM MARY
The urinary steroid pattern of an untreated normotensive 5.5 year old boy with congential virilizing adrenal hyperplasia has been studied.
Abnormally large amounts of metabolites of Compound S and of desoxycorticosterone were found. This indicates that hydroxylation at C-11 of the steroid nucleus was impaired.
The patient also excreted normal or near normal amounts of tetrahydro F, tetrahydro E, and other metabolites possessing an oxygen grouping at C-11. This is interpreted to indicate that the patient was capable of hydroxylation at this position when the adrenals were subjected to excessive stimulation by endogenous ACTH.
Large amounts of metabolites of 17-hydroxyprogesterone were also found. This was interpreted to indicate a relative insufficiency of C-21-hydroxylation when this system was working under a load.
When hypertension accompanies the adrenogenital syndrome it probably indicates a defect in hydroxylation at C-11 of the steroid nucleus and resulting excessive manufacture of DOC. A nor-mal blood pressure does not rule out the existence of this defect. The factors which determine the difference in blood pressure response are not known.
